Intarcia Therapeutics (United States)
Intarcia Therapeutics is an American biopharmaceutical company based in Boston, MA and incorporated under the laws of Delaware. It was founded in 1995 under the name "BioMedicines" and changed to its present name in 2004. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Intarcia Therapeutics (United States), United States, covering academic research published from 2000 to 2023. Read More.
Open Access Percentage
63%
Total
Publications
84
Total Open
Publications
53
Total
Citations
2.4K
Open Access
Percentage
63%
Total
Publications
84
Total Open
Publications
53
Total
Citations
2.4K
Breakdown
Publisher Open
24%
Both
30%
Other Platform Open
9%
Closed
37%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 27%
12
Hybrid 35%
16
No Guarantees 38%
17
Other Platform Open
Domain 73%
24
Preprint 30%
10
Institution 21%
7
Other Internet 18%
6
Public 3%
1
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
DOI | Other Internet | 48 |
PubMed Central | Domain | 24 |
bioRxiv | Preprint | 9 |
Europe PMC | Domain | 5 |
University College London - UCL Discovery | Institution | 2 |
University of North Carolina at Chapel Hill - Carolina Digital Repository | Institution | 1 |
University of Michigan - Deep Blue | Institution | 1 |
University of California - eScholarship University of California | Institution | 1 |
The Deutsches Elektronen-Synchrotron - Desy publication database | Institution | 1 |
Max Planck Society - MPG.PuRe | Institution | 1 |